Gray Kueberuwa | CEO
ImmunoKey

Dr Gray Kueberuwa is Chief Executive Officer of ImmunoKey, a UK-based biotechnology company developing a modular CAR T-cell platform designed to address the key limitations of cell therapy in solid tumours. His work focuses on advancing next-generation, multi-targeted cell therapies toward clinical translation.